Related Experiment Video
Updated: Jul 10, 2025
11:30
Colony Forming Cell CFC Assay for Human Hematopoietic Cells
Published on: December 18, 2010
35.7K
The Hallmarks of Circulating Hybrid Cells
Ranish K Patel1, Michael Parappilly2, Shahrose Rahman1
1Department of Surgery, Oregon Health & Science University, Portland, OR, USA.
Results and Problems in Cell Differentiation
|November 23, 2023
Summary
Novel tumor-immune hybrid cells drive cancer metastasis by combining traits of cancer and immune cells. Understanding these hybrid cells is key to improving cancer prognostication and developing new therapies.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Metastasis is the leading cause of cancer mortality, yet its underlying mechanisms are not fully understood.
- A novel hybrid cell population, formed by the fusion of tumor and immune cells, has been identified.
- These tumor-immune hybrid cells are found in primary tumors, blood, and metastatic sites.
Approach:
- This chapter reviews the current understanding of tumor-immune hybrid cell biology.
- It details how these cells exploit cancer hallmarks to promote progression and metastasis.
- Future research directions and potential therapeutic targets are discussed.
Key Points:
- Tumor-immune hybrid cells exhibit properties of both parental cell types.
- They facilitate cancer cell intravasation, immune evasion, and distant tumor seeding.
- These hybrid cells are crucial players in the metastatic cascade.
Conclusions:
- Tumor-immune hybrid cells significantly contribute to cancer metastasis and patient outcomes.
- Further research into these cells offers potential for improved cancer prognostication.
- Targeting hybrid cell development and dissemination may lead to novel therapeutic strategies.
